Literature DB >> 20688356

High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.

Virawudh Soontornniyomkij1, Cecilia Choi, Justine Pomakian, Harry V Vinters.   

Abstract

The occurrence and progression of cerebral β-amyloid angiopathy and β-amyloid plaques in sporadic Alzheimer's disease may be attributed to aging-related deficiencies in β-amyloid drainage along cerebral perivascular pathways. To elucidate high-definition characteristics of cerebral β-amyloid deposition, we performed immunogold silver staining for β-amyloid-40 and β-amyloid-42 on semithin LR White-embedded tissue sections from 7 Alzheimer's disease/severe cerebral β-amyloid angiopathy, 9 Alzheimer's disease/mild cerebral β-amyloid angiopathy, 5 old control, and 4 young control autopsy brains. In vessel walls, β-amyloid-40 and β-amyloid-42 deposits were unevenly distributed along the adventitia and among the medial smooth muscle cells. β-Amyloid-40 immunoreactivity appeared greater than that of β-amyloid-42 in vessel walls, with β-amyloid-42 being preferentially located on their abluminal regions. In capillary walls, either β-amyloid-40 or β-amyloid-42 deposits or both were present in 6 of 7 severe cerebral β-amyloid angiopathy and in 1 of 9 mild cerebral β-amyloid angiopathy cases, with a marked variation in thickness and focally abluminal excrescences. In 5 of 7 severe cerebral β-amyloid angiopathy cases, a subset of β-amyloid-laden capillaries revealed either β-amyloid-40 or β-amyloid-42 deposits or both radiating from their walls into the surrounding neuropil ("pericapillary deposits"). No vascular β-amyloid-40 or β-amyloid-42 deposits were observed in any of the controls. In conclusion, the patterns of β-amyloid-42 and β-amyloid-40 immunoreactivity in vessel walls suggest that β-amyloid deposits occur in the vascular basement membranes along cerebral perivascular drainage pathways, extending from cortical capillaries to leptomeningeal arteries. The presence of pericapillary β-amyloid deposits suggests that a subset of β-amyloid plaques originate from β-amyloid-laden capillaries, particularly in Alzheimer's disease brains that exhibit preferential capillary involvement by cerebral β-amyloid angiopathy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688356      PMCID: PMC2956850          DOI: 10.1016/j.humpath.2010.04.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  34 in total

Review 1.  Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology.

Authors:  N Joan Abbott
Journal:  Neurochem Int       Date:  2004-09       Impact factor: 3.921

2.  Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.

Authors:  Marsel Mesulam; Pamela Shaw; Deborah Mash; Sandra Weintraub
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

Review 3.  Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

Authors:  James A R Nicoll; Masahito Yamada; Janusz Frackowiak; Bozena Mazur-Kolecka; Roy O Weller
Journal:  Neurobiol Aging       Date:  2004 May-Jun       Impact factor: 4.673

4.  Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease.

Authors:  T Miyakawa; T Kimura; S Hirata; N Fujise; T Ono; K Ishizuka; J Nakabayashi
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

5.  Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.

Authors:  S D Preston; P V Steart; A Wilkinson; J A R Nicoll; R O Weller
Journal:  Neuropathol Appl Neurobiol       Date:  2003-04       Impact factor: 8.090

6.  Two types of sporadic cerebral amyloid angiopathy.

Authors:  Dietmar Rudolf Thal; Estifanos Ghebremedhin; Udo Rüb; Haruyasu Yamaguchi; Kelly Del Tredici; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

7.  Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.

Authors:  Samir Kumar-Singh; Patrick Cras; Rong Wang; John M Kros; Johan van Swieten; Ursula Lübke; Chantal Ceuterick; Sally Serneels; Krist'l Vennekens; Jean-Pierre Timmermans; Eric Van Marck; Jean-Jacques Martin; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

Authors:  Johannes Attems; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-12-04       Impact factor: 17.088

9.  Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections.

Authors:  H V Vinters; W M Pardridge; D L Secor; N Ishii
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

10.  Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy.

Authors:  Virawudh Soontornniyomkij; Matthew D Lynch; Sherin Mermash; Justine Pomakian; Haleh Badkoobehi; Ryan Clare; Harry V Vinters
Journal:  Brain Pathol       Date:  2009-07-16       Impact factor: 6.508

View more
  10 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Authors:  Zhihao Zha; Seok Rye Choi; Karl Ploessl; Brian P Lieberman; Wenchao Qu; Franz Hefti; Mark Mintun; Daniel Skovronsky; Hank F Kung
Journal:  J Med Chem       Date:  2011-11-09       Impact factor: 7.446

3.  Anti-aging effect of fullerenol on skin aging through derived stem cells in a mouse model.

Authors:  Wei Li; Ning Li; Bing Sui; Daping Yang
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

4.  Amyloid-β disrupts unitary calcium entry through endothelial NMDA receptors in mouse cerebral arteries.

Authors:  Emily C Peters; Michael T Gee; Lukas N Pawlowski; Allison M Kath; Felipe D Polk; Christopher J Vance; Juliana L Sacoman; Paulo W Pires
Journal:  J Cereb Blood Flow Metab       Date:  2021-08-31       Impact factor: 6.960

Review 5.  Alzheimer's silent partner: cerebral amyloid angiopathy.

Authors:  Tanya L Cupino; Matthew K Zabel
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 6.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

7.  Increased Aβ pathology in aged Tg2576 mice born to mothers fed a high fat diet.

Authors:  Shereen Nizari; Roxana O Carare; Cheryl A Hawkes
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

8.  Immunotherapy with ponezumab for probable cerebral amyloid angiopathy.

Authors:  Claire Leurent; James A Goodman; Yao Zhang; Ping He; Jonathan R Polimeni; Mahmut Edip Gurol; Monica Lindsay; Linda Frattura; Usharbudh Shivraj Sohur; Anand Viswanathan; Martin M Bednar; Eric E Smith; Steven M Greenberg
Journal:  Ann Clin Transl Neurol       Date:  2019-03-18       Impact factor: 4.511

Review 9.  Outcome markers for clinical trials in cerebral amyloid angiopathy.

Authors:  Steven M Greenberg; Rustam Al-Shahi Salman; Geert Jan Biessels; Mark van Buchem; Charlotte Cordonnier; Jin-Moo Lee; Joan Montaner; Julie A Schneider; Eric E Smith; Meike Vernooij; David J Werring
Journal:  Lancet Neurol       Date:  2014-02-27       Impact factor: 44.182

10.  Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.

Authors:  A Manousopoulou; M Gatherer; C Smith; J A R Nicoll; C H Woelk; M Johnson; R Kalaria; J Attems; S D Garbis; R O Carare
Journal:  Neuropathol Appl Neurobiol       Date:  2016-10-05       Impact factor: 8.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.